Antoine Heron | Stem Cell Bioprocessing Group
Merck Group

Antoine Heron, Stem Cell Bioprocessing Group, Merck Group

Dr Antoine HERON is a cell biologist with expertise in the area of cell therapy and regenerative medicine. His Research and Product development work has led to the commercialization of single-use systems and cell culture media used for the clinical production of human stem cells, in addition to the registration in Europe of innovative solutions for the preservation and transplantation of tissues and organs.

Dr HERON is currently working for the Life Science Division of Merck KGaA (Darmstadt, Germany), within one science-driven organization that is developing advanced solutions for cell and gene therapy manufacturing. He is committed to driving strategic collaboration projects in this field, with academic and industry leading scientists.


Advanced Therapies and Regenerative Medicine Day 1 - Wednesday 16th May 2018 @ 15:30

Implementing Process Optimization to Accelerate Cell Therapy Commercial Readiness

  • Two cases studies will be presented on optimizing approaches for manufacturing at scales necessary for cell-based therapies, (1) human mesenchymal stem cells (hMSCs) on microcarriers, and (2) induced pluripotent stem cells (hiPSCs) as aggregates.
  • Optimized conditions leverage a fed-batch protocol that is easily translated for scale, increases cell yield, and reduces production costs.
  • hMSC and hiPSC characterization for phenotype and function via immunocytochemistry, flow cytometry and cell differentiation to ensure cell-based product quality.

back to speakers



Erica Baeta
+44 (0)207 092 1152


Jessica Robinson
t/ +44 (0)207 092 1150


Issa Mauthoor
+44 (0)207 092 1257